Skip to main content

Nitroglycerin use while Breastfeeding

Medically reviewed by Last updated on Apr 25, 2023.

Drugs containing Nitroglycerin: Nitrostat, Nitrostat Tablets, Nitro-Dur, Tridil, Nitro-Bid, Rectiv, NitroQuick, Nitrolingual Pumpspray, Minitran, Nitrogard, Show all 25 »Nitro-Time, NitroMist, Nitrodisc, Nitroglyn E-R, Nitrol, Nitro TD Patch-A, Transderm-Nitro, Deponit, Nitro-Par, Nitrocot, Nitro-Bid IV, Nitrong, Nitrol Appli-Kit, Nitrek, GoNitro

Nitroglycerin Levels and Effects while Breastfeeding

Summary of Use during Lactation

Topical use of nitroglycerin for anal fissures by nursing mothers appears to have no adverse effects on their breastfed infants. Topical use on the nipples has been used for alleviation of Raynaud phenomenon of the nipples, but only after cessation of breastfeeding.[1] Nitroglycerin should not be used topically on the nipples during breastfeeding. Sublingual and intravenous nitroglycerin have not been studied during breastfeeding. Observe infants for flushing and discomfort after breastfeeding.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Forty nursing mothers used nitroglycerin ointment (dosage not specified) topically for the treatment of postpartum anal fissures for durations ranging from 1 use to 12 months of intermittent use. All but 9 of the women reported side effects from therapy, primarily headache, but also dizziness or lightheadedness. None of the mothers reported any side effects in their breastfed infants.[2]

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.


O'Sullivan S, Keith MP. Raynaud phenomenon of the nipple: a rare finding in rheumatology clinic. J Clin Rheumatol. 2011;17:371-2. [PubMed: 21946463]
Taylor T, Kennedy D. Safety of topical glyceryl trinitrate in the treatment of anal fissure in breastfeeding women. Birth Defects Research Part a-Clinical and Molecular Teratology. 2008;82:411. Abstract. DOI: 10.1002/bdra.20478. [CrossRef]

Substance Identification

Substance Name


CAS Registry Number


Drug Class

  • Breast Feeding
  • Lactation
  • Cardiovascular Agents
  • Vasodilator Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.